Statistics from Altmetric.com
In recent years, there has been a significant increase in the use of inhaled corticosteroids for the prevention of bronchopulmonary dysplasia (BPD) in premature infants.1 Studies have shown a decrease in the rate of BPD and need for prolonged mechanical ventilation. The largest study, to date, investigated the early use of inhaled budesonide in preterm infants and showed a significant decrease in the rate of BPD but a higher mortality rate in the exposure group.2 In this study, the causes of mortality did not differ between inhaled budesonide and placebo group, and the difference in the rate of death appeared to originate from a single centre. This increased mortality had also not been shown in any of previous trials. Nevertheless, this result warrants caution for routine early use of inhaled steroids …
Contributors SS-Z made substantial contribution to the concept of the letter, review of the literature, and drafting the work and its critical revision. JNvdA made substantial contribution to the concept of the letter and its critical revision for intellectual content. Both authors approved the final version of the manuscript and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Author note The authors attest that the manuscript is being submitted only to the Archives of Disease in Childhood, that it will not be submitted elsewhere while under consideration and that it has not been published elsewhere.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.